Finally! Be free from smoking

Debi wrote an interesting post today on

Here’s a quick excerpt
Tuesday, Cyclacel Pharmaceuticals Inc. said it began a Phase 2, open label, single arm, multicenter clinical trial of sapacitabine in patients with non-small cell lung cancer who have had one prior chemotherapy. The study builds on the observation of prolonged stable disease of four months or longer experienced by heavily pretreated non-small cell lung cancer patients involved in two Phase 1 studies of sapacitabine.

Read the rest of this great post here